BNP Paribas Financial Markets’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
BNP Paribas Financial Markets's CODX Position: Q1 2026 in Review
BNP Paribas Financial Markets sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 2 shares — an estimated $10 sold.
BNP Paribas Financial Markets first reported a position in CODX in Q2 2020 and held it in 23 quarters. The position peaked at $764K in Q3 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- BNP Paribas Financial Markets reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- BNP Paribas Financial Markets sold 2 Co-Diagnostics shares in Q1 2026, an estimated $10.
- BNP Paribas Financial Markets first reported a position in Co-Diagnostics in Q2 2020 and held it in 23 quarters.
- BNP Paribas Financial Markets's Co-Diagnostics position peaked at $764K in Q3 2020.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.